Budesonide 200mcg + Formoterol Fumarate Dihydrate 6mcg is a combination inhalation therapy indicated for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). This formulation combines an inhaled corticosteroid (ICS) with a long-acting beta2-adrenergic agonist (LABA) to provide both anti-inflammatory and bronchodilator effects. Budesonide works by reducing inflammation, swelling, and mucus production in the airways, thereby preventing asthma attacks and improving breathing control. Formoterol acts as a long-acting bronchodilator that relaxes airway muscles, providing rapid and sustained relief from bronchospasm. This dual-action therapy helps in: Preventing asthma symptoms Improving lung function Reducing frequency of exacerbations Providing sustained bronchodilation for up to 12 hours It is typically used as maintenance therapy and not intended for immediate relief of acute bronchospasm unless prescribed under SMART therapy guidance.
